Sarcoma Research Studies

< Back to Adolescent and Young Adult Cancer Research Studies Page

Rhabdomyosarcoma New Diagnosis

ARST1431: A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating With Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864, IND#122782) in Patients With Intermediate Risk (IR) Rhabdomyosarcoma (RMS)

  • Conditions: Sarcoma Rhabdomyosarcoma New Diagnosis, Adult - Sarcoma Rhabdomyosarcoma New Diagnosis

PURPOSE: This randomized phase III trial studies how well combination chemotherapy (vincristine sulfate, dactinomycin, cyclophosphamide alternated with vincristine sulfate and irinotecan hydrochloride) works compared to combination chemotherapy plus temsirolimus in treating patients with rhabdomyosa ...More

Contact Us

Contact us.

To learn more about available sarcoma clinical trials, contact us at cancer@cchmc.org or 513-636-2799.